CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 20 enrolled
Drug / intervention
Ropivacaine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02957903
NCT02957903Phase 4Completed
CompareCT.gov

Sensory Distribution of Lateral Femoral Cutaneous Nerve Block - A Randomized, Blinded, Paired Trial in Healthy Volunteers

Zealand University Hospital·interventional·Posted Nov 8, 2016·Updated Jan 26, 2017

In Brief

A Phase 4 clinical trial evaluating Ropivacaine and Isotonic Saline for Nerve Block and 3 related conditions. Completed, enrolled 20 participants across 1 site.

Detailed Summary

The purpose of this study is to investigate and describe the anatomical distribution of the sensory outcome following LFCN block (LFCN = lateral femoral cutaneous nerve) in relation to the incisional lines after Total Hip Arthroplasty (THA). Furthermore, is the aim to examine whether there is a motorial outcome corresponding to the Femoral nerve. The trial will be conducted in healthy volunteers in a blinded, randomized paired study.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNerve Block, Anesthesia, Local, Pain, Postoperative, Anatomical Distribution
CountriesDenmark
CollaboratorsNaestved Hospital

Timeline

Phase 4CompletedFinished
2017201820192020202120222023202420252026
First PostedNov 8, 2016
Enrollment StartNov 1, 2016
Primary CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 9.7 years ago

Interventions

Ropivacainedrug

All 20 study participants will receive both treatment A and B in form of a nerve block injection around the lateral femoral cutaneous nerve. Treatment A and B will be randomized to be given in either right or left lower extremity. If the participant is randomized to receive treatment A in the right lower extremity, treatment B will be given in the left lower extremity, and vice versa. Each participant will thus constitute as their own control.

Isotonic Salinedrug

All 20 study participants will receive both treatment A and B in form of a nerve block injection around the lateral femoral cutaneous nerve. Treatment A and B will be randomized to be given in either right or left lower extremity. If the participant is randomized to receive treatment A in the right lower extremity, treatment B will be given in the left lower extremity, and vice versa. Each participant will thus constitute as their own control.